141 related articles for article (PubMed ID: 30314963)
21. Opt-out bloodborne virus screening: a cross-sectional observational study in an acute medical unit.
Allen N; Faherty C; Davies A; Lyons A; Scarry M; Bohan Keane M; Boyle N; O'Connell S; McCarthy E; Keady D; Bergin C; Lee J; Fleming C; Gallagher D; Tuite H
BMJ Open; 2019 Jul; 9(7):e022777. PubMed ID: 31315851
[TBL] [Abstract][Full Text] [Related]
22. Dried blood spots, valid screening for viral hepatitis and human immunodeficiency virus in real-life.
Mössner BK; Staugaard B; Jensen J; Lillevang ST; Christensen PB; Holm DK
World J Gastroenterol; 2016 Sep; 22(33):7604-12. PubMed ID: 27672281
[TBL] [Abstract][Full Text] [Related]
23. Transmission of hepatitis B, hepatitis C and human immunodeficiency viruses through unsafe injections in the developing world: model-based regional estimates.
Kane A; Lloyd J; Zaffran M; Simonsen L; Kane M
Bull World Health Organ; 1999; 77(10):801-7. PubMed ID: 10593027
[TBL] [Abstract][Full Text] [Related]
24. Hepatitis C Treatment Uptake Following Dried Blood Spot Testing for Hepatitis C RNA in New South Wales, Australia: The NSW DBS Pilot Study.
Conway A; Stevens A; Murray C; Prain B; Power C; McNulty A; Carrington N; Lu H; Kingsland M; McGrath C; Read P; Starr M; Catlett B; Cunningham P; Grebely J
Open Forum Infect Dis; 2023 Nov; 10(11):ofad517. PubMed ID: 38023551
[TBL] [Abstract][Full Text] [Related]
25. Routine screening for HIV, hepatitis B virus and hepatitis C virus in individuals undergoing oral and maxillofacial surgery.
Assoumou L; Thormann F; Soulié C; Caby F; Dudoit Y; Marcelin AG; Goudot P; Blanc C; Coriat P; Katlama C; Costagliola D; Pourcher V
HIV Med; 2019 May; 20(5):353-358. PubMed ID: 30924598
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infections Among Transgender Persons Referred to an Italian Center for Total Sex Reassignment Surgery.
Luzzati R; Zatta M; Pavan N; Serafin M; Maurel C; Trombetta C; Barbone F
Sex Transm Dis; 2016 Jul; 43(7):407-11. PubMed ID: 27322038
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017).
Scheibe A; Young K; Versfeld A; Spearman CW; Sonderup MW; Prabdial-Sing N; Puren A; Hausler H
BMC Infect Dis; 2020 Sep; 20(1):655. PubMed ID: 32894072
[TBL] [Abstract][Full Text] [Related]
28. Home collection for frequent HIV testing: acceptability of oral fluids, dried blood spots and telephone results. HIV Early Detection Study Group.
Spielberg F; Critchlow C; Vittinghoff E; Coletti AS; Sheppard H; Mayer KH; Metzgerg D; Judson FN; Buchbinder S; Chesney M; Gross M
AIDS; 2000 Aug; 14(12):1819-28. PubMed ID: 10985320
[TBL] [Abstract][Full Text] [Related]
29. HIV and hepatitis B and C co-infection among people who inject drugs in Zanzibar.
Khatib A; Matiko E; Khalid F; Welty S; Ali A; Othman A; Haji S; Dahoma M; Rutherford G
BMC Public Health; 2017 Nov; 17(1):917. PubMed ID: 29183287
[TBL] [Abstract][Full Text] [Related]
30. Utility of a one-step screening and diagnosis strategy for viremic HCV infection among people who inject drugs in Catalonia.
Saludes V; Antuori A; Folch C; González N; Ibáñez N; Majó X; Colom J; Matas L; Casabona J; Martró E;
Int J Drug Policy; 2019 Dec; 74():236-245. PubMed ID: 31706159
[TBL] [Abstract][Full Text] [Related]
31. Co-infection assessment in HBV, HCV, and HIV patients in Western Saudi Arabia.
Al-Mughales JA
J Med Virol; 2016 Sep; 88(9):1545-51. PubMed ID: 26895691
[TBL] [Abstract][Full Text] [Related]
32. Screening for retroviruses and hepatitis viruses using dried blood spots reveals a high prevalence of occult hepatitis B in Ghana.
de Mendoza C; Bautista JM; Pérez-Benavente S; Kwawu R; Fobil J; Soriano V; Díez A
Ther Adv Infect Dis; 2019; 6():2049936119851464. PubMed ID: 31205689
[TBL] [Abstract][Full Text] [Related]
33. Dried Blood Spot Tests for the Diagnosis and Therapeutic Monitoring of HIV and Viral Hepatitis B and C.
Tuaillon E; Kania D; Pisoni A; Bollore K; Taieb F; Ontsira Ngoyi EN; Schaub R; Plantier JC; Makinson A; Van de Perre P
Front Microbiol; 2020; 11():373. PubMed ID: 32210946
[TBL] [Abstract][Full Text] [Related]
34. Community-based screening of hepatitis C with a one-step RNA detection algorithm from dried-blood spots: Analysis of key populations in Barcelona, Spain.
Saludes V; Folch C; Morales-Carmona A; Ferrer L; Fernàndez-López L; Muñoz R; Jiménez M; Loureiro E; Fernández-Dávila P; Bascuñana E; Casabona J; Martró E
J Viral Hepat; 2018 Mar; 25(3):236-244. PubMed ID: 29053912
[TBL] [Abstract][Full Text] [Related]
35. Hepatitis B and C infection at a large public sector hospital clinic: is it a burden?
Kurira P; Ndhlovu CE; Gomo ZA
Cent Afr J Med; 2014; 60(9-12):56-62. PubMed ID: 26867256
[TBL] [Abstract][Full Text] [Related]
36. Testing for hepatitis B virus and HIV in patients with chronic hepatitis C: screening performance and outcome.
Bolther M; Dalgaard LS; Kristensen LH; Tarp BD; Jensen-Fangel S
Scand J Infect Dis; 2014 Oct; 46(10):686-92. PubMed ID: 25134654
[TBL] [Abstract][Full Text] [Related]
37. Sero-prevalence of hepatitis B and C viral infections in Ghanaian HIV positive cohort: a consideration for their health care.
Pappoe F; Hagan CKO; Obiri-Yeboah D; Nsiah P
BMC Infect Dis; 2019 May; 19(1):380. PubMed ID: 31053100
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of human immunodeficiency virus, hepatitis C virus, hepatitis B virus and syphilis among individuals attending anonymous testing for HIV in Luanda, Angola.
Guimarães Nebenzahl H; Lopes A; Castro R; Pereira F
S Afr Med J; 2013 Jan; 103(3):186-8. PubMed ID: 23472697
[TBL] [Abstract][Full Text] [Related]
39. Protocol for a cluster randomised controlled trial of secondary distribution of hepatitis C self-testing within the context of a house-to-house hepatitis C micro-elimination programme in Karachi, Pakistan.
Shilton S; Ali D; Hasnain A; Abid A; Markby J; Jamil MS; Luhmann N; Nabeta P; Ongarello S; Reipold EI; Hamid S
BMC Public Health; 2022 Apr; 22(1):696. PubMed ID: 35397544
[TBL] [Abstract][Full Text] [Related]
40. Simultaneous Human Immunodeficiency Virus-Hepatitis B-Hepatitis C Point-of-Care Tests Improve Outcomes in Linkage-to-Care: Results of a Randomized Control Trial in Persons Without Healthcare Coverage.
Bottero J; Boyd A; Gozlan J; Carrat F; Nau J; Pauti MD; Rougier H; Girard PM; Lacombe K
Open Forum Infect Dis; 2015 Dec; 2(4):ofv162. PubMed ID: 26668814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
